Dr. McCandless is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13121 E 17th Ave
L-28 4th Floor MS 8400
Aurora, CO 80045Phone+1 303-724-2370- Is this information wrong?
Summary
- Dr. Shawn McCandless is a medical geneticist in Aurora, CO and is affiliated with Children's Hospital Colorado. He received his medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 29 years. He specializes in clinical biochemical genetics, clinical genetics, and medical biochemical genetics and is experienced in prader-willi syndrome, mitochondrial diseases, inborn errors of metabolism, intellectual disability, and neonatal screening.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Medical Biochemical Genetics, 2003 - 2005
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Medical Genetics and Genomics, 1996 - 1999
- University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1988 - 1991
- Lewis Katz School of Medicine at Temple UniversityClass of 1988
Certifications & Licensure
- CO State Medical License 2018 - 2025
- WY State Medical License 2021 - 2024
- OH State Medical License 1998 - 2018
- NC State Medical License 1999 - 2004
- WI State Medical License 1989 - 1999
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Longitudinal Study of Urea Cycle Disorders Start of enrollment: 2006 Feb 01
- Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome Start of enrollment: 2014 Sep 01
- A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Start of enrollment: 2014 Dec 31
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPiloting a multidisciplinary approach to improve outcomes of fetal whole exome sequencing: An overview of workflow and case example.Kestutis C Micke, Hannah M Elfman, Katherine A Fantauzzo, Patrick S McGrath, David E Clouthier, Shawn E McCandless, Austin Larson, Manesha Putra, Bettina F Cuneo, Regi...> ;Prenatal Diagnosis. 2023 Apr 1
- 6 citationsIntranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.Elizabeth Roof, Cheri L Deal, Shawn E McCandless, Ronald L Cowan, Jennifer L Miller, Jill K Hamilton, Elizabeth R Roeder, Shana E McCormack, Tamanna R Roshan Lal, Huss...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Jun 16
- 26 citationsEfficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.Sarah C Grünert, Terry G J Derks, Katarina Adrian, Khalid Al-Thihli, Diana Ballhausen, Joanna Bidiuk, Andrea Bordugo, Monica Boyer, Drago Bratkovic, Michaela Brunner-K...> ;Genetics in Medicine. 2022 Aug 1
- Join now to see all
Press Mentions
- University of Colorado Anschutz Medical Campus Named ‘Rare Disease Center of Excellence’February 8th, 2022
- Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi SyndromeJune 24th, 2023
Professional Memberships
- Member
- American College of Medical Genetics and GenomicsFellow
- Society for Inherited Metabolic DisordersMember
- American Society of Human GeneticsMember
Hospital Affiliations
- Children's Hospital ColoradoAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: